Protein Misfolding Enteropathy Predicts and Prognosticates Neurodegenerative Disease Years Before Symptom Onset.

Protein misfolding enteropathy detected in GI biopsies predicts neurodegenerative disease with over 80% sensitivity up to 7 years before symptoms.

• Why it matters: Early identification of neurodegenerative disorders is critical for effective intervention, but current biomarkers are limited and often only detectable after significant neuronal damage.
• What they did: Researchers analyzed archival gastrointestinal biopsies from 196 individuals, using histopathologic staining to identify misfolded TDP-43, tau, and α-synuclein, and tracked disease development over 13-15 years.
• The result: Presence of GI proteinopathy predicted neurodegeneration years before symptoms, with a dose-dependent impact on survival, offering a scalable biomarker platform for early diagnosis and intervention.